InVivo Therapeutics' creditors voted to approve the company's Chapter 11 liquidation plan, according to a June 17 declaration filed in the U.S. Bankruptcy Court for the District of Delaware.
The company initially filed for Chapter 11 bankruptcy protection in February. At that time the company asked the court to continue business practices and a potential sale of assets during the bankruptcy process, according to SEC filings.
InVivo Therapeutics' implants are designed for patients with acute thoracic spinal cord injuries, according to its website.